J
Jong Kil Lee
Researcher at Kyung Hee University
Publications - 29
Citations - 663
Jong Kil Lee is an academic researcher from Kyung Hee University. The author has contributed to research in topics: Neuroinflammation & Amyloid beta. The author has an hindex of 9, co-authored 29 publications receiving 333 citations.
Papers
More filters
Journal ArticleDOI
Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer’s Disease
Jong Kil Lee,Nam-Jung Kim +1 more
TL;DR: Recent advances in the targeting of p38 MAPK as a potential strategy for the treatment of AD are summarized and possibilities of p 38 MAPK inhibitors as a fundamental therapeutics for AD are envisioned.
Journal ArticleDOI
Transplantation of gut microbiota derived from Alzheimer's disease mouse model impairs memory function and neurogenesis in C57BL/6 mice.
TL;DR: In this article, the authors performed fecal microbiota transplantation (FMT) to clarify the role of 5xFAD mouse-derived microbiota in memory decline, and found that FMT from 5x-FAD mice into normal C57BL/6 mice (5×FAD-FMT), decreased adult hippocampal neurogenesis and brain-derived neurotrophic factor expression and increased p21 expression.
Journal ArticleDOI
A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse
Min Sung Gee,Seung Hwan Son,Seung Ho Jeon,Jimin Do,Namkwon Kim,Yeon-Joo Ju,Soo Jin Lee,Eun Kyoung Chung,Kyung-Soo Inn,Nam-Jung Kim,Jong Kil Lee +10 more
TL;DR: Based on the data, p38 MAPK inhibition is a potential strategy for AD therapy, suggesting NJK14047 as one of the promising candidates for AD therapeutics targeting p38MAPKs.
Journal ArticleDOI
Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling.
TL;DR: This study suggests that RSV NS1 interacts with TRIM25 and interferes with RIG-I ubiquitination to suppress type-I interferon signaling.
Journal ArticleDOI
Piperlongumine inhibits neuroinflammation via regulating NF-κB signaling pathways in lipopolysaccharide-stimulated BV2 microglia cells.
Namkwon Kim,Jimin Do,Jae-sung Bae,Hee Kyung Jin,Jong Ho Kim,Kyung-Soo Inn,Myung Sook Oh,Jong Kil Lee +7 more
TL;DR: Piperlongumine is found to be a candidate agent for the treatment of inflammation-related neurodegenerative diseases and exerted its anti-neuroinflammatory effects by suppressing the nuclear factor kappa B signaling pathway.